The fight to end malaria is at a critical juncture. After years of progress, momentum has stalled – putting millions of people at risk, especially pregnant women and children under 5.
Hard-won gains are under threat from multiple converging challenges. Drug and insecticide resistance are weakening the tools we rely on. At the same time, population growth, extreme weather events, conflict, humanitarian pressures and declining investment are leaving more communities exposed and vulnerable.
But the path ahead is clear. With decisive action and smart investment, we can end this disease.
We have the tools to end malaria – and more are on the way. Sustained funding and increased investment in proven interventions and innovations can get the fight against malaria back on track. But these tools must reach those most at risk.
The Global Fund is working with partners to support country-led solutions – helping to make these lifesaving tools affordable and available at scale, while prioritizing people who need them most.
Driven to End Malaria: Now We Can. Now We Must.
Where Bullets Fly, Malaria Kills
In a camp in Darfur, an infant develops a fever. All too often, the cause is malaria, a disease that flourishes in the chaos of conflict. If the family can access prompt diagnosis and treatment, the child is unlikely to develop a severe case of the disease, let alone die. But time is of the essence. Survival rates plummet if the parasite is left undetected and untreated for more than a couple of days. Where health care facilities have been destroyed, medical supply chains disrupted and health workers overwhelmed by the sheer volume of cases, too many children are dying because conflict prevents timely access to care.
Kenya risks a resurgence of malaria. These children are trying to stop it
Just before dawn, students stream through the bright pink gates of St. Anne’s Ahero Comprehensive School in Kisumu County in western Kenya. It’s the start of a school day – and the mosquitoes are hungry. Clouds of them descend from the dense canopy of trees growing high above the school yard. In the pre-dawn darkness, even more mosquitoes crowd around classroom doors, waiting for a chance to bite.
A Decade of Progress: Halting Drug-Resistant Malaria in Southeast Asia
Artemisinin is a powerful antimalarial drug – a key ingredient in medicines that cure malaria quickly and save millions of lives. But in Southeast Asia’s Mekong region – Cambodia, the Lao People’s Democratic Republic (Lao PDR), Myanmar, Thailand and Viet Nam – malaria parasites have evolved to resist this lifesaving drug.